1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adagene Inc (ADAG)

  7. Adagene Inc (ADAG) Financials

ADAG

Adagene Inc
1.50
-0.02 (-1.32%)
Upgrade to Real-Time

Adagene Inc. (ADAG) Fundamentals
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
SHARE INFORMATION
Market CapUS$ 66,453,244
Shares Outstanding43,252,567
Float43,252,567
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 10,175,258
Latest Fiscal EPSUS$ -1.83
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions25
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months-
Institutional Holdings Percent10.7%
Institutional Sold Previous 3 Months1,726,975
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week HighUS$ 4.74
52 Week LowUS$ 0.90
52 Week High ChangeUS$ -65.63
21 Day Moving AverageUS$ 1.6224
21 Day Extended Moving AverageUS$ 1.6146
50 Day Moving AverageUS$ 1.7519
50 Day Extended Moving AverageUS$ 1.6302
200 Day Moving AverageUS$ 1.5445
200 Day Extended Moving AverageUS$ 2.4133
10 Day Average Volume16,551
20 Day Average Volume14,255
30 Day Average Volume13,498
50 Day Average Volume21,654
Alpha-0.088249
Beta0.0693
Standard Deviation0.194191
R20.000393
7 Day Price ChangeUS$ -0.0636
7 Day Percent Change-3.98%
21 Day Price ChangeUS$ -0.2736
21 Day Percent Change-15.12%
30 Day Price ChangeUS$ -0.1936
30 Day Percent Change-11.19%
Month to Date Price ChangeUS$ -0.1273
Month to Date Percent Change-7.65%
Quarter to Date Price ChangeUS$ 0.2114
Quarter to Date Percent Change15.95%
180 Day Price ChangeUS$ 0.1664
180 Day Percent Change12.15%
200 Day Price ChangeUS$ 0.0164
200 Day Percent Change1.08%
Year to Date Price ChangeUS$ 0.2114
Year to Date Percent Change15.95%

Adagene Inc. (ADAG) Key Ratios

PROFITABILITY
EBIT Margin-635.7%
EBITDA Margin-635.7%
Pre-Tax Profit Margin-2,377.5%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 3,923,174
Revenue Per ShareUS$ 0.0907
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity0.20
Int Coverage-211.80
Current Ratio3.10
Leverage Ratio1.60
Quick Ratio3.00
Long Term Debt To Capital0.08
VALUATION MEASURES
PE Ratio-0.90
Enterprise ValueUS$ -83,996,323
Price to Sales16.9386
Price to Free Cash-1.10
PE High Last 5 Years0.00
Price To Book0.60
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.90
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-45.07
Return on Equity-60.33
Return on Capital-51.56

Adagene Inc. (ADAG) Profile

PROFILE INFO
Issue TypeAD
SEC Type-
AuditorPricewaterhouseCoopers Zhong Tian LLP
CEOPeter Luo
Emplyoees259
Last AuditUQ
CIK0001818838
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
AddressXinghu Street, Suzhou Industrial Park
4th Floor, Building C14, No. 218
Suzhou, 215123
Websitehttps://www.adagene.com
Facsimile-
Telephone+86 51287773616
Email-
Your Recent History
NASDAQ
ADAG
Adagene
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 11:10:38